November 2nd 2023.
"It Takes Two" by Rob Base is a classic hit, but it's taking on a new meaning in a health initiative to combat chronic kidney disease. Boehringer Ingelheim and Eli Lilly and Company have partnered with the iconic artist to create a remix that encourages CKD testing.
The title of the remix is a reference to the two tests needed to accurately determine one's level of progression or risk of developing CKD. These tests include an eGFR for blood and UACR for urine. Early diagnosis is especially important for those with type 2 diabetes, as the illness can often lead to CKD.
Dr. Charles Irvine of UC Irvine School of Medicine's Associate Dean of Diversity and Inclusion spoke about the importance of the initiative. “The unique approach of ‘It Takes 2’ in reaching two different audiences with two different but equally valuable messages is a critical step forward in improving the treatment of adults in jeopardy of developing kidney disease,” he shared.
CKD can have a life-threatening impact on the cardiorenal metabolic system, yet many individuals aren't aware of their status. The awareness campaign is aiming to remedy this problem. Dr. Mohamed Eid, executive at Boehringer Ingelheim, said, “It Takes Two is a defining piece of music history and the Boehringer Ingelheim and Lilly Alliance is excited to partner with Rob Base to reinvent this song to amplify the mission of our new health initiative. It Takes 2 is driving attention to the value of using two complementary tests to help identify unmet needs of the at-risk population and reduce risks associated with the growing burden of CKD.”
The initiative is especially important for the Black community, which is significantly impacted by CKD. To learn more about the initiative and to listen to the new version of the song, visit their website. Let's keep spreading the word and encourage everyone to get tested!
[This article has been trending online recently and has been generated with AI. Your feed is customized.]
[Generative AI is experimental.]
